Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Core Informatics and ChemAxon Renew Partnership

Published: Saturday, April 06, 2013
Last Updated: Friday, April 05, 2013
Bookmark and Share
Partnership joins ChemAxon's cheminformatics toolkit suite with Core Informatics' LIMS and ELN.

Core Informatics, a leading provider of data management solutions to the life sciences, molecular diagnostics, and energy industries, and ChemAxon, a leader in providing chemistry software solutions and consulting services for life science research, have renewed a multi-year partnership.  The Partnership, established in 2007, joins ChemAxon's growing cheminformatics toolkit suite with Core Informatics' web-based Laboratory Information Management System (Core LIMS) and Electronic Lab Notebook (Core ELN).

The Core LIMS & ELN offer a wide array of features through a flexible component-based architecture that provides organizations with individually tailored solutions to support their data management needs.  The Chemical Registration Application, powered by ChemAxon, enables users within the Core LIMS to lever the power of ChemAxon's cheminformatics toolkits designed to optimize the value of chemistry information in pharmaceutical R&D.  The application's functionality includes, but is not limited to, compound registration, structure visualization and searching, reaction enumeration and calculated properties.

"ChemAxon has been a valued partner over the last 5 years," said Anthony Uzzo, President of Core Informatics. "More importantly, the union of ChemAxon's toolkit suite with the structured data management environment of the Core LIMS continues to provide competitive advantage for our existing and new clients in an important business segment for the organization."

"Our long-standing partnership with Core has been very productive for both companies and to the over 25 customers using the combined platform.  It is a great example of how our chemistry toolkit, which is the partner of choice for companies wishing to extend their chemistry capabilities, helps to deliver a real value for money and high performance solution to the market," said Alex Drijver, CEO of ChemAxon.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Richard R. Duffy Joins Core Informatics As Director of Customer Success
Duffy to be responsible for professional services, support and customer satisfaction.
Saturday, January 11, 2014
Core Informatics Names Josh Geballe as CEO
Geballe joins Core after over a decade at IBM where he held international executive roles spanning general management, finance and strategy.
Thursday, October 03, 2013
Core Informatics Selected as Connecticut Technology Council (CTC) 2013 Marcum Tech Top 40 Award Winner for Second Time
Core Informatics is one of the State's 40 Fastest Growing Tech Companies
Saturday, August 24, 2013
Core Informatics and OpenEye Scientific Software Forge Partnership
New partnership integrates OpenEye cheminformatics software into Core Informatics' web-based LIMS and ELN
Tuesday, May 07, 2013
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!